Amy Reilly

Investor Relations Kontakt bei DYNE THERAPEUTICS, INC.

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von Amy Reilly

Unternehmen	Position	Beginn	Ende
DYNE THERAPEUTICS, INC.	Investor Relations Kontakt	01.07.2020	-
DYNE THERAPEUTICS, INC.	Public Communications Contact	01.07.2020	-

Unternehmen	Position	Beginn	Ende
KALEIDO BIOSCIENCES, INC.	Investor Relations Kontakt	01.09.2018	01.05.2020
KALEIDO BIOSCIENCES, INC.	Public Communications Contact	01.11.2017	01.05.2020
THERMO FISHER SCIENTIFIC	Public Communications Contact	01.03.2017	01.10.2017
IMMUNOGEN, INC.	Public Communications Contact	01.10.2015	01.03.2017
CUBIST PHARMACEUTICALS INC	Public Communications Contact	01.01.2011	01.01.2015

Bowdoin College

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Public Communications Contact	5
Investor Relations Contact	2
Undergraduate Degree	1

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
KALEIDO BIOSCIENCES, INC.	Health Technology
DYNE THERAPEUTICS, INC.	Health Technology
THERMO FISHER SCIENTIFIC	Health Technology

Private Unternehmen	2
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.	Health Technology